<DOC>
	<DOCNO>NCT00881270</DOCNO>
	<brief_summary>Primary Objective : To prove safety formulation normal condition use .</brief_summary>
	<brief_title>Dermacyd Infantile - Acceptability .</brief_title>
	<detailed_description />
	<criteria>Inclusion criterion : Integral skin test region Use category cosmetic Willingness follow study procedure present clinic day schedule time . Exclusion criterion : Use Antiinflammatory , immunosuppressant antihistaminic drug Allergic atopic history cosmetic product Cutaneous active disease ( local general ) evaluate area Disease cause immunosuppressant , diabetes , HIV Endocrine pathology Intensive solar exposure 15 day evaluation Treatment four month selection . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>